APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alvimopan

Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.

Selected research

Market Outlook & Growth Opportunities

Global Alvimopan Market Outlook and Growth Opportunities 2026

28 December 2025192 pages

Choose your research edition.

Industry ResearchAlvimopan Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Alvimopan Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Alvimopan Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alvimopan Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Alvimopan Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.

Alvimopan (CAS 156053-89-3) is widely used in Pharmaceutical and Other field. The most proportion of Alvimopan (CAS 156053-89-3) is used in Pharmaceutical, and the proportion in 2019 is 88.64%. Market competition is intense. Merck is the leaders of the industry, and they hold key technologies and patents, with high-end customers.

This report provides an overview of the global Alvimopan market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Alvimopan and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alvimopan sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alvimopan market size, projected growth trends, production technologies, key applications, and end-use industries.

Alvimopan Segment by Company

Merck

Teva Pharmaceutical Industries Ltd

MSN Life Sciences Private Ltd

Alvimopan Segment by Type

Pharmaceutical Grade

Others

Alvimopan Segment by Application

Pharmaceutical

Other

Alvimopan Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Alvimopan status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Alvimopan market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Alvimopan significant trends, drivers, influence factors in global and regions.

6. To analyze Alvimopan competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alvimopan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alvimopan and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alvimopan.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Alvimopan market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Alvimopan industry.

Chapter 3: Detailed analysis of Alvimopan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Alvimopan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Alvimopan in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Alvimopan Industry Trends Table 2. Alvimopan Industry Drivers Table 3. Alvimopan Industry Opportunities and Challenges Table 4. Alvimopan Industry Restraints Table 5. Global Alvimopan Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Alvimopan Revenue Share by Company (2021-2026) Table 7. Global Alvimopan Sales Volume by Company (KG) & (2021-2026) Table 8. Global Alvimopan Sales Volume Share by Company (2021-2026) Table 9. Global Alvimopan Average Price (US$/g) of Company (2021-2026) Table 10. Global Alvimopan Company Ranking, (2024-2026) & (USD Million) Table 11. Global Alvimopan Key Company Manufacturing Base & Headquarters Table 12. Global Alvimopan Company, Product Type & Application Table 13. Global Alvimopan Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Alvimopan by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Pharmaceutical Grade Table 18. Significant Companies of Others Table 19. Global Alvimopan Sales Volume by Type 2021 VS 2025 VS 2032 (KG) Table 20. Global Alvimopan Sales Volume by Type (2021-2026) & (KG) Table 21. Global Alvimopan Sales Volume by Type (2027-2032) & (KG) Table 22. Global Alvimopan Sales Volume Share by Type (2021-2026) Table 23. Global Alvimopan Sales Volume Share by Type (2027-2032) Table 24. Global Alvimopan Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Alvimopan Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Alvimopan Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Alvimopan Sales Value Share by Type (2021-2026) Table 28. Global Alvimopan Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Pharmaceutical Table 30. Significant Companies of Other Table 31. Global Alvimopan Sales Volume by Application 2021 VS 2025 VS 2032 (KG) Table 32. Global Alvimopan Sales Volume by Application (2021-2026) & (KG) Table 33. Global Alvimopan Sales Volume by Application (2027-2032) & (KG) Table 34. Global Alvimopan Sales Volume Share by Application (2021-2026) Table 35. Global Alvimopan Sales Volume Share by Application (2027-2032) Table 36. Global Alvimopan Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Alvimopan Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Alvimopan Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Alvimopan Sales Value Share by Application (2021-2026) Table 40. Global Alvimopan Sales Value Share by Application (2027-2032) Table 41. Global Alvimopan Sales by Region: 2021 VS 2025 VS 2032 (KG) Table 42. Global Alvimopan Sales by Region (2021-2026) & (KG) Table 43. Global Alvimopan Sales Market Share by Region (2021-2026) Table 44. Global Alvimopan Sales by Region (2027-2032) & (KG) Table 45. Global Alvimopan Sales Market Share by Region (2027-2032) Table 46. Global Alvimopan Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Alvimopan Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Alvimopan Sales Value Share by Region (2021-2026) Table 49. Global Alvimopan Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Alvimopan Sales Value Share by Region (2027-2032) Table 51. Global Alvimopan Market Average Price (US$/g) by Region (2021-2026) Table 52. Global Alvimopan Market Average Price (US$/g) by Region (2027-2032) Table 53. Global Alvimopan Sales by Country: 2021 VS 2025 VS 2032 (KG) Table 54. Global Alvimopan Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Alvimopan Sales by Country (2021-2026) & (KG) Table 56. Global Alvimopan Sales Market Share by Country (2021-2026) Table 57. Global Alvimopan Sales by Country (2027-2032) & (KG) Table 58. Global Alvimopan Sales Market Share by Country (2027-2032) Table 59. Global Alvimopan Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Alvimopan Sales Value Market Share by Country (2021-2026) Table 61. Global Alvimopan Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Alvimopan Sales Value Market Share by Country (2027-2032) Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Alvimopan Sales (KG), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 66. Merck Alvimopan Product Portfolio Table 67. Merck Recent Development Table 68. Teva Pharmaceutical Industries Ltd Company Information Table 69. Teva Pharmaceutical Industries Ltd Business Overview Table 70. Teva Pharmaceutical Industries Ltd Alvimopan Sales (KG), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 71. Teva Pharmaceutical Industries Ltd Alvimopan Product Portfolio Table 72. Teva Pharmaceutical Industries Ltd Recent Development Table 73. MSN Life Sciences Private Ltd Company Information Table 74. MSN Life Sciences Private Ltd Business Overview Table 75. MSN Life Sciences Private Ltd Alvimopan Sales (KG), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 76. MSN Life Sciences Private Ltd Alvimopan Product Portfolio Table 77. MSN Life Sciences Private Ltd Recent Development Table 78. Key Raw Materials Table 79. Raw Materials Key Suppliers Table 80. Alvimopan Distributors List Table 81. Alvimopan Customers List Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Alvimopan Product Image Figure 2. Global Alvimopan Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alvimopan Sales Value (2021-2032) & (US$ Million) Figure 4. Global Alvimopan Sales (2021-2032) & (KG) Figure 5. Global Alvimopan Sales Average Price (US$/g) & (2021-2032) Figure 6. Global Alvimopan Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Pharmaceutical Grade Image Figure 10. Others Image Figure 11. Global Alvimopan Sales Volume by Type (2021 VS 2025 VS 2032) & (KG) Figure 12. Global Alvimopan Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Alvimopan Sales Volume Share by Type (2021-2032) Figure 14. Global Alvimopan Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Alvimopan Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Alvimopan Sales Value Share by Type (2021-2032) Figure 17. Pharmaceutical Image Figure 18. Other Image Figure 19. Global Alvimopan Sales Volume by Application (2021 VS 2025 VS 2032) & (KG) Figure 20. Global Alvimopan Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Alvimopan Sales Volume Share by Application (2021-2032) Figure 22. Global Alvimopan Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Alvimopan Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Alvimopan Sales Value Share by Application (2021-2032) Figure 25. Global Alvimopan Sales by Region: 2021 VS 2025 VS 2032 (KG) Figure 26. Global Alvimopan Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Alvimopan Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Alvimopan Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Alvimopan Sales Value (2021-2032) & (US$ Million) Figure 30. North America Alvimopan Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Alvimopan Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Alvimopan Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Alvimopan Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Alvimopan Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Alvimopan Sales Value (2021-2032) & (US$ Million) Figure 36. South America Alvimopan Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Alvimopan Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Alvimopan Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Alvimopan Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Alvimopan Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Alvimopan Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Alvimopan Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Alvimopan Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceutical Grade
  • Others
Applications
  • Pharmaceutical
  • Other
Companies covered
  • Merck
  • Teva Pharmaceutical Industries Ltd
  • MSN Life Sciences Private Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alvimopan Sales Value (2021-2032)
  4. 1.2.2 Global Alvimopan Sales Volume (2021-2032)
  5. 1.2.3 Global Alvimopan Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Alvimopan Market Dynamics
  1. 2.1 Alvimopan Industry Trends
  2. 2.2 Alvimopan Industry Drivers
  3. 2.3 Alvimopan Industry Opportunities and Challenges
  4. 2.4 Alvimopan Industry Restraints
3 Alvimopan Market by Company
  1. 3.1 Global Alvimopan Company Revenue Ranking in 2025
  2. 3.2 Global Alvimopan Revenue by Company (2021-2026)
  3. 3.3 Global Alvimopan Sales Volume by Company (2021-2026)
  4. 3.4 Global Alvimopan Average Price by Company (2021-2026)
  5. 3.5 Global Alvimopan Company Ranking (2024-2026)
  6. 3.6 Global Alvimopan Company Manufacturing Base and Headquarters
  7. 3.7 Global Alvimopan Company Product Type and Application
  8. 3.8 Global Alvimopan Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Alvimopan Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Alvimopan Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Alvimopan Market by Type
  1. 4.1 Alvimopan Type Introduction
  2. 4.1.1 Pharmaceutical Grade
  3. 4.1.2 Others
  4. 4.2 Global Alvimopan Sales Volume by Type
  5. 4.2.1 Global Alvimopan Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Alvimopan Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Alvimopan Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Alvimopan Sales Value by Type
  9. 4.3.1 Global Alvimopan Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Alvimopan Sales Value by Type (2021-2032)
  11. 4.3.3 Global Alvimopan Sales Value Share by Type (2021-2032)
5 Alvimopan Market by Application
  1. 5.1 Alvimopan Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Other
  4. 5.2 Global Alvimopan Sales Volume by Application
  5. 5.2.1 Global Alvimopan Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Alvimopan Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Alvimopan Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Alvimopan Sales Value by Application
  9. 5.3.1 Global Alvimopan Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Alvimopan Sales Value by Application (2021-2032)
  11. 5.3.3 Global Alvimopan Sales Value Share by Application (2021-2032)
6 Alvimopan Regional Sales and Value Analysis
  1. 6.1 Global Alvimopan Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alvimopan Sales by Region (2021-2032)
  3. 6.2.1 Global Alvimopan Sales by Region: 2021-2026
  4. 6.2.2 Global Alvimopan Sales by Region (2027-2032)
  5. 6.3 Global Alvimopan Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Alvimopan Sales Value by Region (2021-2032)
  7. 6.4.1 Global Alvimopan Sales Value by Region: 2021-2026
  8. 6.4.2 Global Alvimopan Sales Value by Region (2027-2032)
  9. 6.5 Global Alvimopan Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Alvimopan Sales Value (2021-2032)
  12. 6.6.2 North America Alvimopan Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Alvimopan Sales Value (2021-2032)
  15. 6.7.2 Europe Alvimopan Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Alvimopan Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Alvimopan Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Alvimopan Sales Value (2021-2032)
  21. 6.9.2 South America Alvimopan Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Alvimopan Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Alvimopan Sales Value Share by Country, 2025 VS 2032
7 Alvimopan Country-level Sales and Value Analysis
  1. 7.1 Global Alvimopan Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Alvimopan Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Alvimopan Sales by Country (2021-2032)
  4. 7.3.1 Global Alvimopan Sales by Country (2021-2026)
  5. 7.3.2 Global Alvimopan Sales by Country (2027-2032)
  6. 7.4 Global Alvimopan Sales Value by Country (2021-2032)
  7. 7.4.1 Global Alvimopan Sales Value by Country (2021-2026)
  8. 7.4.2 Global Alvimopan Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Alvimopan Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Alvimopan Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Alvimopan Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Alvimopan Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Alvimopan Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Alvimopan Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Alvimopan Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Alvimopan Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Alvimopan Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Alvimopan Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Alvimopan Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Alvimopan Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Alvimopan Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Alvimopan Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Alvimopan Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Alvimopan Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Alvimopan Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Alvimopan Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Alvimopan Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Alvimopan Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Alvimopan Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Alvimopan Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Alvimopan Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Alvimopan Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Alvimopan Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Alvimopan Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Alvimopan Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Alvimopan Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Alvimopan Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Alvimopan Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Alvimopan Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Alvimopan Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Alvimopan Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Alvimopan Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Alvimopan Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Alvimopan Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Alvimopan Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Alvimopan Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Alvimopan Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Alvimopan Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Alvimopan Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Alvimopan Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Alvimopan Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Alvimopan Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Alvimopan Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Alvimopan Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Alvimopan Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Alvimopan Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Alvimopan Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Alvimopan Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Alvimopan Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Alvimopan Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Alvimopan Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Alvimopan Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Alvimopan Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Alvimopan Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Alvimopan Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Alvimopan Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Alvimopan Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Alvimopan Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Alvimopan Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Alvimopan Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Alvimopan Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Alvimopan Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Alvimopan Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Alvimopan Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Alvimopan Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Alvimopan Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Alvimopan Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Alvimopan Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Alvimopan Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Alvimopan Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Alvimopan Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Alvimopan Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Alvimopan Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Alvimopan Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Alvimopan Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Alvimopan Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Alvimopan Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Alvimopan Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Alvimopan Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Alvimopan Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Alvimopan Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Alvimopan Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Alvimopan Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck Alvimopan Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Teva Pharmaceutical Industries Ltd
  8. 8.2.1 Teva Pharmaceutical Industries Ltd Company Information
  9. 8.2.2 Teva Pharmaceutical Industries Ltd Business Overview
  10. 8.2.3 Teva Pharmaceutical Industries Ltd Alvimopan Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Teva Pharmaceutical Industries Ltd Alvimopan Product Portfolio
  12. 8.2.5 Teva Pharmaceutical Industries Ltd Recent Developments
  13. 8.3 MSN Life Sciences Private Ltd
  14. 8.3.1 MSN Life Sciences Private Ltd Company Information
  15. 8.3.2 MSN Life Sciences Private Ltd Business Overview
  16. 8.3.3 MSN Life Sciences Private Ltd Alvimopan Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 MSN Life Sciences Private Ltd Alvimopan Product Portfolio
  18. 8.3.5 MSN Life Sciences Private Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Alvimopan Value Chain Analysis
  2. 9.1.1 Alvimopan Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Alvimopan Sales Mode & Process
  6. 9.2 Alvimopan Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Alvimopan Distributors
  9. 9.2.3 Alvimopan Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst